Garnette D. Draper

Array ( [id] => 4346131 [patent_doc_number] => 06214559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Methods of identifying inhibitors of binding of IL-13 to the IL-13 receptor chain' [patent_app_type] => 1 [patent_app_number] => 8/841751 [patent_app_country] => US [patent_app_date] => 1997-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7793 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214559.pdf [firstpage_image] =>[orig_patent_app_number] => 841751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062457 [patent_doc_number] => 06007998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Leptin assay' [patent_app_type] => 1 [patent_app_number] => 8/837635 [patent_app_country] => US [patent_app_date] => 1997-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5568 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007998.pdf [firstpage_image] =>[orig_patent_app_number] => 837635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995334 [patent_doc_number] => 05922573 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'IL-1 receptor antagonists with enhanced inhibitory activity' [patent_app_type] => 1 [patent_app_number] => 8/809185 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6741 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922573.pdf [firstpage_image] =>[orig_patent_app_number] => 809185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045319 [patent_doc_number] => 05874535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Human leptin receptor gene-related protein' [patent_app_type] => 1 [patent_app_number] => 8/843370 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16623 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874535.pdf [firstpage_image] =>[orig_patent_app_number] => 843370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986507 [patent_doc_number] => 05910431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Polynucleotides encoding chemokine .alpha.-2' [patent_app_type] => 1 [patent_app_number] => 8/825556 [patent_app_country] => US [patent_app_date] => 1997-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 21389 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910431.pdf [firstpage_image] =>[orig_patent_app_number] => 825556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567662 [patent_doc_number] => 06376659 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Nucleic acids encoding a novel neutrophil chemotactic factor' [patent_app_type] => B1 [patent_app_number] => 08/818631 [patent_app_country] => US [patent_app_date] => 1997-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1541 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376659.pdf [firstpage_image] =>[orig_patent_app_number] => 08818631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262282 [patent_doc_number] => 06204372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'DNA encoding a human tubby homolog' [patent_app_type] => 1 [patent_app_number] => 8/812824 [patent_app_country] => US [patent_app_date] => 1997-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17062 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204372.pdf [firstpage_image] =>[orig_patent_app_number] => 812824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3923978 [patent_doc_number] => 05952197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'DNA encoding the chemotactic cytokine III' [patent_app_type] => 1 [patent_app_number] => 8/812003 [patent_app_country] => US [patent_app_date] => 1997-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20601 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952197.pdf [firstpage_image] =>[orig_patent_app_number] => 812003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176735 [patent_doc_number] => 06084075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2)' [patent_app_type] => 1 [patent_app_number] => 8/734171 [patent_app_country] => US [patent_app_date] => 1997-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/084/06084075.pdf [firstpage_image] =>[orig_patent_app_number] => 734171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050692 [patent_doc_number] => 05869639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Human p24 vesicle proteins' [patent_app_type] => 1 [patent_app_number] => 8/801740 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19302 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869639.pdf [firstpage_image] =>[orig_patent_app_number] => 801740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050692 [patent_doc_number] => 05869639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Human p24 vesicle proteins' [patent_app_type] => 1 [patent_app_number] => 8/801740 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19302 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869639.pdf [firstpage_image] =>[orig_patent_app_number] => 801740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050692 [patent_doc_number] => 05869639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Human p24 vesicle proteins' [patent_app_type] => 1 [patent_app_number] => 8/801740 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19302 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869639.pdf [firstpage_image] =>[orig_patent_app_number] => 801740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050692 [patent_doc_number] => 05869639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Human p24 vesicle proteins' [patent_app_type] => 1 [patent_app_number] => 8/801740 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19302 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869639.pdf [firstpage_image] =>[orig_patent_app_number] => 801740 [rel_patent_id] =>[rel_patent_doc_number] =>)